Medicine and Dentistry
Adverse Event
50%
Cellular Immunity
50%
Clinical Trial
50%
Coronavirinae
50%
COVID-19
50%
COVID-19 Vaccination
50%
COVID-19 Vaccine
100%
Disease
50%
Humoral Immunity
50%
Immunogenicity
100%
Population
50%
Vaccine
100%
Keyphrases
Adverse Events
25%
Booster Vaccination
25%
Cellular Immune Response
25%
Clinical High Risk
25%
COVID-19
25%
COVID-19 Vaccination
25%
COVID-19 Vaccine
100%
High Risk
25%
Humoral Immune Response
25%
Patients with Cancer
100%
Pivotal Trial
25%
Primary Vaccination
25%
Tumor Immunogenicity
100%
Vaccine Effectiveness
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
25%
Clinical Trial
25%
Coronavirinae
25%
COVID-19 Vaccine
100%
Disease
25%
Immunogenicity
100%
Malignant Neoplasm
100%
Vaccination Policy
50%
Vaccine
50%
Immunology and Microbiology
Adoptive Immunity
20%
Coronavirinae
20%
COVID-19
100%
Humoral Immunity
20%
Immunogenicity
100%
Population
20%
Vaccination Policy
40%
Vaccine Efficacy
100%